First Phase 1b, single-center, age de-escalation trial of theP. falciparumblood-stage malaria vaccine candidate RH5.1/Matrix-M™: a delayed boost regimen induces high levels of functional antibodies in 5-17 month old Tanzanian infants

Silk SE., Kalinga WF., Salkeld J., Mtaka IM., Ahmed S., Milando F., Diouf A., Bundi CK., Balige N., Hassan O., Mkindi CG., Rwezaula S., Athumani T., Mswata S., Lilolime NS., Simon B., Msami H., Mohamed M., David DM., Mohammed L., Nyaulingo G., Mwalimu B., Juma O., Mwamlima TG., Sasamalo IA., Mkumbange RP., Kamage JJ., Barrett JR., King LDW., Hou MM., Pulido D., Carnrot C., Lawrie AM., Cowan RE., Nugent FL., Roberts R., Cho J-S., Long CA., Nielsen CM., Miura K., Draper SJ., Olotu AI., Minassian AM.

DOI

10.1101/2024.03.25.24304862

Type

Publication Date

26/03/2024

Permalink Original publication